Carisma Therapeutics Shares Soar Over 130% on Groundbreaking Moderna Collaboration for In Vivo CAR-M Therapies
Kohl's Q2 Earnings on the Horizon: Wall Street Weighs In With Shifting Forecasts and Price Target Adjustments